Dror Bashan - 19 Oct 2023 Form 4 Insider Report for Protalix BioTherapeutics, Inc. (PLX)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Dror Bashan
Issuer symbol
PLX
Transactions as of
19 Oct 2023
Net transactions value
+$90,484
Form type
4
Filing time
20 Oct 2023, 06:50:07 UTC
Previous filing
17 Aug 2023
Next filing
04 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLX Common Stock Purchase $67,742 +48,387 +71% $1.40 116,387 19 Oct 2023 Direct
transaction PLX Common Stock Purchase $22,742 +16,129 +14% $1.41 132,516 19 Oct 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.